Skip to content
healthcare.dev

BUTALBITAL and ACETAMINOPHEN

NDC 70752-147, BUTALBITAL and ACETAMINOPHEN, tablet, from QUAGEN PHARMACEUTICALS LLC.

Product NDC
70752-147
Status
Listed
Labeler
QUAGEN PHARMACEUTICALS LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214305
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70752-147 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUTALBITAL50 mg/1
  • ACETAMINOPHEN300 mg/1

Pharmacologic classes

Barbiturate [EPC]; Barbiturates [CS]

Package NDCNDC-11Package
70752-147-1070752014710100 TABLET in 1 BOTTLE, PLASTIC (70752-147-10)
70752-147-1470752014714500 TABLET in 1 BOTTLE, PLASTIC (70752-147-14)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1f0dbe62-6aea-4323-ad25-c2211f919253
  • NADAC price for package 70752014710

    GET /v1/drugs/nadac/70752014710

Use it

Look up 70752-147 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70752-147 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70752-147. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.